Malignant Neck Neoplasm — Trials

Malignant Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,145 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 607
Recruiting: 330
Ph III recruiting: 76
Growth YoY: +6.3%
Industry share: 10%
Top sponsor: Sun Yat-sen University
Termination share: 27.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 51–60 of 60 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01267240	Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer	terminated	Phase 2	25	National Cancer Institute (NCI)NIH	2	Apr 14, 2017	clinicaltrials
NCT00599131	Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE)	terminated	Phase 2	4	University of Michigan Rogel Cancer CenterOTHER	1	Dec 3, 2015